We evaluated the influence of TLR7 rs179009 on disease development among patients of HBeAg(+) and observed that among the male individuals of HBeAg(+), the frequency of allele A was decreased from 87.7% in patients with CHB to 68.2% in those with HCC. Here, TLR7 is linked to hepatocellular carcinoma.